Although currently no significant differences in reducing AHI have been identified between GLP-1 RAs alone or in combination with CPAP versus CPAP alone, patients with obesity and OSA may consider GLP-1 RA as a potential treatment option if the adverse events are deemed tolerable
Popular Stories Upcoming Events
Ashwagandha contains other potentially beneficial bioactive compounds such as flavonoids, tannins, and amino acids that may contribute to overall health benefits
Refuerzo de brillo + mantenimiento
Some patients may notice reductions in fasting and post-meal glucose levels within the first 12 weeks of starting treatment, as semaglutide begins to enhance insulin secretion and suppress glucagon
Less common but more serious risks include pancreatitis, vision changes, kidney problems, and gallbladder issues